Advertisement

Clinical Drug Investigation

, Volume 22, Issue 6, pp 403–405 | Cite as

Weekly Formulation of Fluoxetine for Newly Treated Patients with Depression

  • Gary S. Kabinoff
  • John M. Plewes
  • Michael G. Wilson
Short Communication

Keywords

Depressive Symptom Major Depressive Disorder Fluoxetine Sexual Dysfunction Major Depressive Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

This article was sponsored in part by an unrestricted educational grant from Eli Lilly and Company, Indianapolis, IN, USA.

References

  1. 1.
    Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry 1991; 52 Suppl. 5: 28–34PubMedGoogle Scholar
  2. 2.
    Katon W, VonKorff M, Lin E, et al. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992; 30: 67–76PubMedCrossRefGoogle Scholar
  3. 3.
    Hirschfeld RM, Keller MB, Panico S, et al. The national depressive and manic-depressive association consensus statement on the undertreatment of depression. JAMA 1997; 277: 333–40PubMedCrossRefGoogle Scholar
  4. 4.
    Montgomery SA, Baldwin D, Shah A, et al. Plasma-level response relationships with fluoxetine and zimelidine. Clin Neuropharmacol 1990; 13 Suppl. 1: S71–5PubMedCrossRefGoogle Scholar
  5. 5.
    Finley PR. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. Ann Pharmacother 1994; 28(12): 1359–69PubMedGoogle Scholar
  6. 6.
    Schmidt ME, Fava M, et al. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder. J Clin Psychiatry 2000; 61: 851–7PubMedCrossRefGoogle Scholar
  7. 7.
    Claxton A, de Klerk E, et al. Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder. J Clin Psychiatry 2000; 61: 928–32PubMedCrossRefGoogle Scholar
  8. 8.
    Buongiorno PA, Plewes JM, Wilson MG. Cohort experience in 39 psychiatric outpatients with high doses of an entericcoated weekly formulation of fluoxetine. Clin Drug Invest 2002; 22(3): 173–9CrossRefGoogle Scholar
  9. 9.
    Wagstaff AJ, Goa KL. Once-weekly fluoxetine. Drugs 2001; 61(15): 2221–8PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2002

Authors and Affiliations

  • Gary S. Kabinoff
    • 1
  • John M. Plewes
    • 2
  • Michael G. Wilson
    • 3
  1. 1.Martin Memorial Medical CenterStuartUSA
  2. 2.Lilly Research LaboratoriesIndianapolis, DC 4133USA
  3. 3.College of Pharmacy and Health Sciences, Butler UniversityIndianapolisUSA

Personalised recommendations